Published in Thyroid on April 01, 2003
An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg (2010) 2.81
Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy. World J Surg (2010) 2.75
Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid (2013) 2.66
Ultrasonography and the ultrasound-based management of thyroid nodules: consensus statement and recommendations. Korean J Radiol (2011) 2.49
The prevalence and prognostic value of BRAF mutation in thyroid cancer. Ann Surg (2007) 2.36
Risk Factors for Central Compartment Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Meta-Analysis. World J Surg (2015) 2.09
Papillary microcarcinoma. World J Surg (2008) 1.96
Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J Surg (2010) 1.86
Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg (2006) 1.63
Exclusion of malignancy in thyroid nodules with indeterminate fine-needle aspiration cytology after negative 18F-fluorodeoxyglucose positron emission tomography: interim analysis. World J Surg (2010) 1.57
Circulating Myeloid-Derived Suppressor Cells Predict Differentiated Thyroid Cancer Diagnosis and Extent. Thyroid (2016) 1.41
Increasing incidence of thyroid cancer: controversies explored. Nat Rev Endocrinol (2013) 1.31
Papillary microcarcinoma of the thyroid: how should it be treated? World J Surg (2004) 1.26
Preoperative ultrasonographic examination for lymph node metastasis: usefulness when designing lymph node dissection for papillary microcarcinoma of the thyroid. World J Surg (2004) 1.24
Rare potential complications of thyroid fine needle biopsy. Hippokratia (2011) 1.16
Incidences of Unfavorable Events in the Management of Low-Risk Papillary Microcarcinoma of the Thyroid by Active Surveillance Versus Immediate Surgery. Thyroid (2015) 1.16
Papillary thyroid microcarcinoma: extrathyroidal extension, lymph node metastases, and risk factors for recurrence in a high prevalence of goiter area. World J Surg (2010) 1.14
Contralateral papillary thyroid cancer: does size matter? Am J Surg (2009) 1.14
Increasing detection and increasing incidence in thyroid cancer. World J Surg (2009) 1.09
'Aggressive papillary' thyroid microcarcinoma. Eur Arch Otorhinolaryngol (2009) 1.04
Brief report: Use and misuse of thyroid ultrasound in the initial workup of patients with suspected thyroid problems referred by primary care physicians to an endocrine clinic. J Gen Intern Med (2005) 1.03
Lateral lymph node dissection guided by preoperative and intraoperative findings in differentiated thyroid carcinoma. World J Surg (2008) 1.02
Advances in surgical therapy for thyroid cancer. Nat Rev Endocrinol (2011) 1.01
Papillary microcarcinoma: is there any difference between clinically overt and occult tumors? World J Surg (2006) 0.99
Risk factors for nodal metastasis and recurrence among patients with papillary thyroid microcarcinoma: differences in clinical relevance between nonincidental and incidental tumors. World J Surg (2009) 0.99
Polo-like kinase 1 overexpression is an early event in the progression of papillary carcinoma. Br J Cancer (2004) 0.98
Thyroid incidentaloma: an evidence-based assessment of management strategy. World J Surg (2008) 0.98
Needle tract implantation of papillary thyroid carcinoma after fine-needle aspiration biopsy. World J Surg (2005) 0.98
BRAF mutation in papillary thyroid microcarcinoma: the promise of better risk management. Ann Surg Oncol (2009) 0.98
Natural History of Asymptomatic Papillary Thyroid Microcarcinoma: Time-Dependent Changes in Calcification and Vascularity During Active Surveillance. World J Surg (2016) 0.96
Thyroid incidentalomas: to treat or not to treat. Eur Arch Otorhinolaryngol (2010) 0.94
Thyroid nodules: risk stratification for malignancy with ultrasound and guided biopsy. Cancer Imaging (2011) 0.93
Recurrence of papillary thyroid cancer after optimized surgery. Gland Surg (2015) 0.93
Factors predictive of papillary thyroid micro-carcinoma with bilateral involvement and central lymph node metastasis: a retrospective study. World J Surg Oncol (2012) 0.93
Managing thyroid microcarcinomas. Yonsei Med J (2012) 0.93
Nonoperative management of low-risk differentiated thyroid carcinoma. Curr Opin Oncol (2015) 0.92
Clinical Trials of Active Surveillance of Papillary Microcarcinoma of the Thyroid. World J Surg (2016) 0.91
Access, excess, and overdiagnosis: the case for thyroid cancer. Cancer Med (2014) 0.91
Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma: indications, benefits, and risks. World J Surg (2007) 0.91
Ill-defined edge on ultrasonographic examination can be a marker of aggressive characteristic of papillary thyroid microcarcinoma. World J Surg (2005) 0.90
Prevalence of thyroid cancer at a medical screening center: pathological features of screen-detected thyroid carcinomas. Yonsei Med J (2008) 0.89
Clinical characteristics of papillary thyroid microcarcinoma less than or equal to 5 mm on ultrasonography. Eur Arch Otorhinolaryngol (2013) 0.89
Prognostic parameters for recurrence of papillary thyroid microcarcinoma. BMC Cancer (2008) 0.88
Incidental papillary microcarcinoma of the thyroid--factors affecting lymph node metastasis. Langenbecks Arch Surg (2007) 0.88
The pros and cons of routine central compartment neck dissection for clinically nodal negative (cN0) papillary thyroid cancer. Gland Surg (2013) 0.87
Association between serum thyrotropin concentration and growth of asymptomatic papillary thyroid microcarcinoma. World J Surg (2014) 0.87
Ultrasound-guided fine-needle aspiration biopsy of thyroid nodules smaller than 5 mm in the maximum diameter: assessment of efficacy and pathological findings. Korean J Radiol (2009) 0.86
Prognosis of patients with benign thyroid diseases accompanied by incidental papillary carcinoma undetectable on preoperative imaging tests. World J Surg (2007) 0.86
Evaluating thyroid nodules: predicting and selecting malignant nodules for fine-needle aspiration (FNA) cytology. Insights Imaging (2013) 0.85
Global DNA methylation evaluation: potential complementary marker in differential diagnosis of thyroid neoplasia. Virchows Arch (2005) 0.85
Prevalence of thyroid nodules and carcinomas in patients operated on for renal hyperparathyroidism: experience with 339 consecutive patients and review of the literature. World J Surg (2005) 0.85
Multi-targeted approach in the treatment of thyroid cancer. Ther Clin Risk Manag (2008) 0.85
The role of preoperative neck ultrasounds to assess lymph nodes in patients with suspicious or indeterminate thyroid nodules. J Surg Oncol (2011) 0.84
Clinical outcome, role of BRAF(V600E), and molecular pathways in papillary thyroid microcarcinoma: is it an indolent cancer or an early stage of papillary thyroid cancer? Front Endocrinol (Lausanne) (2012) 0.84
Clinical features and prognostic factors in papillary thyroid microcarcinoma depends on age. J Korean Surg Soc (2012) 0.84
Prognostic factors of papillary and follicular carcinomas in Japan based on data of kuma hospital. J Thyroid Res (2011) 0.84
Management of low-risk papillary thyroid carcinoma: unique conventional policy in Japan and our efforts to improve the level of evidence. Surg Today (2010) 0.83
Occult thyroid carcinoma. Acta Otorhinolaryngol Ital (2009) 0.83
Factors influencing the outcome of patients with incidental papillary thyroid microcarcinoma. J Thyroid Res (2012) 0.82
Association between screening and the thyroid cancer "epidemic" in South Korea: evidence from a nationwide study. BMJ (2016) 0.82
Revisiting Low-Risk Thyroid Papillary Microcarcinomas Resected Without Observation: Was Immediate Surgery Necessary? World J Surg (2016) 0.81
Is surgery necessary for papillary thyroid microcarcinomas? Nat Rev Endocrinol (2011) 0.81
Favorable surgical results in 433 elderly patients with papillary thyroid cancer. World J Surg (2005) 0.80
Prevalence of unsuspected thyroid nodules in adults on contrast enhanced 16- and 64-MDCT of the chest. World J Radiol (2012) 0.80
Outcome of Subclassification of Indeterminate (Thy-3) Thyroid Cytology into Thy-3a and Thy-3f. Eur Thyroid J (2015) 0.79
E-cadherin expression and cell proliferation in the primary tumor and metastatic lymph nodes of papillary thyroid microcarcinoma. Mol Clin Oncol (2013) 0.79
A Risk Model for Predicting Central Lymph Node Metastasis of Papillary Thyroid Microcarcinoma Including Conventional Ultrasound and Acoustic Radiation Force Impulse Elastography. Medicine (Baltimore) (2016) 0.79
Clinical significance of incidental thyroid nodules identified on low-dose CT for lung cancer screening. Multidiscip Respir Med (2013) 0.79
Completion lobectomy and central compartment dissection in low-risk patients who had undergone less extensive surgery than hemithyroidectomy. Oncol Lett (2012) 0.78
Thyroid cancer detected by mass screening over a period of 16 years at a health care center in Japan. Surg Today (2006) 0.78
Randomization to screening for prostate, lung, colorectal and ovarian cancers and thyroid cancer incidence in two large cancer screening trials. PLoS One (2014) 0.78
Age and prognosis of papillary thyroid carcinoma: retrospective stratification into three groups. J Korean Surg Soc (2012) 0.78
Partial Thyroidectomy for Papillary Thyroid Microcarcinoma: Is Completion Total Thyroidectomy Indicated? World J Surg (2016) 0.78
Malignancy rate in sonographically suspicious thyroid nodules of less than a centimeter in size does not decrease with decreasing size. J Korean Med Sci (2011) 0.77
Negative Fine-Needle Aspiration in Patients with Goiter: Should We Doubt It? World J Surg (2016) 0.77
The pattern and significance of the calcifications of papillary thyroid microcarcinoma presented in preoperative neck ultrasonography. Ann Surg Treat Res (2014) 0.76
Does true Gleason pattern 3 merit its cancer descriptor? Nat Rev Urol (2016) 0.76
Significance of prophylactic modified radical neck dissection for patients with low-risk papillary thyroid carcinoma measuring 1.1-3.0 cm: first report of a trial at Kuma Hospital. Surg Today (2011) 0.76
Retrospective Analysis of 255 Papillary Thyroid Carcinomas ≤2 cm: Clinicohistological Features and Prognostic Factors. Eur Thyroid J (2014) 0.75
Solitary pulmonary metastasis from occult papillary thyroid carcinoma. Thorac Cancer (2015) 0.75
Effects of Pregnancy on Papillary Microcarcinomas of the Thyroid Re-Evaluated in the Entire Patient Series at Kuma Hospital. Thyroid (2015) 0.75
Differences in the Form of Presentation between Papillary Microcarcinomas and Papillary Carcinomas of Larger Size. J Thyroid Res (2010) 0.75
Papillary thyroid microcarcinoma: the significance of high risk features. BMC Cancer (2017) 0.75
Screening without evidence of efficacy: thyroid ultrasonography is another example. BMJ (2004) 0.75
No considerable changes in papillary thyroid microcarcinoma characteristics over a 30-year time period. BMC Res Notes (2016) 0.75
Thyroid nodules and evaluation of thyroid cancer risk. Australas J Ultrasound Med (2015) 0.75
Thyroid gland: Pregnancy--a risk factor for thyroid surgery complications. Nat Rev Endocrinol (2009) 0.75
Sonographic and Clinical Features of Papillary Thyroid Microcarcinoma Less than or Equal to Five Millimeters: A Retrospective Study. PLoS One (2016) 0.75
Clinical and histopathological characteristics of patients with incidental and nonincidental thyroid cancer. Arch Med Sci (2016) 0.75
Preoperative predictors of lateral neck lymph node metastasis in papillary thyroid microcarcinoma. Medicine (Baltimore) (2017) 0.75
Hepatocyte Growth Factor/C-Met Axis in Thyroid Cancer: From Diagnostic Biomarker to Therapeutic Target. Biomark Insights (2017) 0.75
Thyroid ultrasonography. World J Surg (2010) 0.75
2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma. Cancer Biol Med (2017) 0.75
The incidence and risk factors for central lymph node metastasis in cN0 papillary thyroid microcarcinoma: a meta-analysis. Eur Arch Otorhinolaryngol (2016) 0.75
[Fine-needle aspiration (FNA) of the thyroid gland : Analysis of discrepancies between cytological and histological diagnoses]. Pathologe (2016) 0.75
Controversies in the Management of Low-Risk Differentiated Thyroid Cancer. Endocr Rev (2017) 0.75
Occult papillary thyroid microcarcinoma manifesting only as a symptomatic lateral cervical mass: report of a case. Surg Today (2012) 0.75
Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome. J Endocrinol Invest (2017) 0.75
Direct control of shoot meristem activity by a cytokinin-activating enzyme. Nature (2007) 3.27
An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg (2010) 2.81
Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy. World J Surg (2010) 2.75
Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid (2013) 2.66
Electrophysiologic recurrent laryngeal nerve monitoring during thyroid and parathyroid surgery: international standards guideline statement. Laryngoscope (2011) 2.55
Surgical complications of posterior lumbar interbody fusion with total facetectomy in 251 patients. J Neurosurg Spine (2006) 2.11
BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patients. Endocr J (2008) 2.06
Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis. Cancer Res (2002) 2.02
Thermodilution-derived coronary blood flow pattern immediately after coronary intervention as a predictor of microcirculatory damage and midterm clinical outcomes in patients with ST-segment-elevation myocardial infarction. Circ Cardiovasc Interv (2014) 1.99
Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy. Thyroid (2011) 1.96
Four cases of Graves' disease which developed after painful Hashimoto's thyroiditis. Intern Med (2006) 1.90
Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells. Pharmacogenet Genomics (2005) 1.85
Our experience of treatment of cribriform morular variant of papillary thyroid carcinoma; difference in clinicopathological features of FAP-associated and sporadic patients. Endocr J (2011) 1.72
A mutant high-density lipoprotein receptor inhibits proliferation of human breast cancer cells. Cancer Res (2004) 1.67
Risk factors for adjacent segment degeneration after PLIF. Spine (Phila Pa 1976) (2004) 1.65
Usefulness of thyroglobulin measurement in fine-needle aspiration biopsy specimens for diagnosing cervical lymph node metastasis in patients with papillary thyroid cancer. World J Surg (2005) 1.63
Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg (2006) 1.63
Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection. World J Surg (2007) 1.58
Palatal mucosal measurements in a Japanese population using cone-beam computed tomography. J Esthet Restor Dent (2013) 1.55
Surgical strategy for cervical myelopathy due to ossification of the posterior longitudinal ligament: Part 2: Advantages of anterior decompression and fusion over laminoplasty. Spine (Phila Pa 1976) (2007) 1.54
Prognostic factors and therapeutic strategies for differentiated carcinomas of the thyroid. Endocr J (2008) 1.53
Silencing the constitutive active transcription factor CREB by the LKB1-SIK signaling cascade. FEBS J (2006) 1.49
Thyrotoxicosis caused by weight-reducing herbal medicines. Arch Intern Med (2005) 1.49
Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease. J Clin Endocrinol Metab (2007) 1.49
Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily. Thyroid (2009) 1.48
Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease. Clin Endocrinol (Oxf) (2009) 1.47
Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up. World J Surg (2012) 1.47
Serum concentrations of granulocyte colony-stimulating factor (G-CSF) in antithyroid drug-induced agranulocytosis. Endocr J (2004) 1.46
Surgical strategy for cervical myelopathy due to ossification of the posterior longitudinal ligament: Part 1: Clinical results and limitations of laminoplasty. Spine (Phila Pa 1976) (2007) 1.46
Mutational analysis of the APC gene in cribriform-morula variant of papillary thyroid carcinoma. World J Surg (2006) 1.46
Third molar position: reliability of panoramic radiography. J Oral Maxillofac Surg (2007) 1.45
Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients. World J Surg (2012) 1.43
Cone-beam CT with flat-panel-detector digital angiography system: early experience in abdominal interventional procedures. Cardiovasc Intervent Radiol (2006) 1.42
Transient hyperthyroidism after withdrawal of antithyroid drugs in patients with Graves' disease. Endocr J (2004) 1.41
Papillary Thyroid Carcinoma in Children and Adolescents: Long-Term Follow-Up and Clinical Characteristics. World J Surg (2015) 1.41
External branch of the superior laryngeal nerve monitoring during thyroid and parathyroid surgery: International Neural Monitoring Study Group standards guideline statement. Laryngoscope (2013) 1.40
Environmental sex determination in the branchiopod crustacean Daphnia magna: deep conservation of a Doublesex gene in the sex-determining pathway. PLoS Genet (2011) 1.39
Ernest L. Mazzaferri, MD, MACP (1936-2013). Thyroid (2013) 1.39
Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World J Surg (2006) 1.39
CT domain of CCN2/CTGF directly interacts with fibronectin and enhances cell adhesion of chondrocytes through integrin alpha5beta1. FEBS Lett (2006) 1.38
A deubiquitinating enzyme UBPY regulates the level of protein ubiquitination on endosomes. Traffic (2006) 1.38
Improvement in phonation after reconstruction of the recurrent laryngeal nerve in patients with thyroid cancer invading the nerve. Surgery (2009) 1.37
Identification of the nuclear receptor CAR:HSP90 complex in mouse liver and recruitment of protein phosphatase 2A in response to phenobarbital. FEBS Lett (2003) 1.37
Distinct diagnostic criteria for ultrasonographic examination of papillary thyroid carcinoma: a multicenter study. Thyroid (2005) 1.36
A therapeutic strategy for incidentally detected papillary microcarcinoma of the thyroid. Nat Clin Pract Endocrinol Metab (2007) 1.35
Distinct clinical, serological, and sonographic characteristics of hashimoto's thyroiditis based with and without IgG4-positive plasma cells. J Clin Endocrinol Metab (2010) 1.34
FINE CULM1 (FC1) works downstream of strigolactones to inhibit the outgrowth of axillary buds in rice. Plant Cell Physiol (2010) 1.33
SNPs in the promoter of a B cell-specific antisense transcript, SAS-ZFAT, determine susceptibility to autoimmune thyroid disease. Hum Mol Genet (2004) 1.32
Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe. World J Surg (2006) 1.32